Repligen Corporation - Common Stock (RGEN) stock analysis

RGEN · Repligen Corporation - Common Stock

Latest recorded price: USD 162.78

Sector and industry: Healthcare · Medical Instruments & Supplies

A reliable intrinsic value could not be calculated for RGEN; the assessment relies on sector multiple comparisons. Fiscal 2017 figures: revenue growth 30.5%, ROIC 3.9%.

Similar companies in Healthcare